Difficulty: Medium
Average Score: 65%
Practice
One of your obese female patients is coming to review her recent lab results. Her HgbA1C is 12.1. She reports she just cannot seem to commit herself to an appropriate nutritional lifestyle. There were no other abnormalities noted with her lab results. With your understanding of the current ADA standards of care which of the following medications will you include in the plan for this patient?
Correct answer
D
Rationale
ADA standards recommend Metformin (D) as first-line therapy for type 2 diabetes due to its efficacy in reducing hepatic glucose production and improving insulin sensitivity, especially with HgbA1C of 12.1 indicating poor control. Rosiglitazone (A) and Glipizide (B) are not first-line, and Acarbose (C) is less effective here.